Charles River Laboratories International, Inc. (CRL) — Financial statements
Income statement, balance sheet, and cash flow for Charles River Laboratories International, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4,015↓0.9% | 4,050↓1.9% | 4,129↑3.9% | 3,976↑12.3% | 3,540 | |
| Cost of Revenue | 2,790↑2.6% | 2,718↑3.5% | 2,627↑4.5% | 2,513↑14.0% | 2,206 | |
| Gross Profit | 1,226↓8.0% | 1,332↓11.4% | 1,503↑2.7% | 1,463↑9.6% | 1,335 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 743↓1.1% | 751↑0.4% | 748↑12.4% | 665↑7.3% | 620 | |
| Other Expenses | -25↓107.2% | 353↑157.2% | 137↓6.2% | 147↑17.4% | 125 | |
| Operating Expenses | 718↓35.0% | 1,104↑24.8% | 885↑9.1% | 812↑9.0% | 745 | |
| Total Costs & Expenses | 3,508↓8.2% | 3,823↑8.8% | 3,512↑5.6% | 3,325↑12.7% | 2,950 | |
| Operating Results | ||||||
| Operating Income | 508↑123.4% | 227↓63.2% | 617↓5.2% | 651↑10.4% | 590 | |
| Depreciation & Amortization | 403↑11.5% | 362↑15.2% | 314↑3.4% | 304↑14.4% | 266 | |
| EBITDA | 911↑56.8% | 581↓43.7% | 1,032↑4.7% | 986↑20.2% | 820 | |
| EBIT | 508↑131.5% | 219↓69.4% | 718↑5.2% | 682↑23.0% | 555 | |
| Interest & Other Income | ||||||
| Net Interest Income | -102↑13.3% | -118↑10.5% | -132↓124.8% | -59↑20.1% | -73 | |
| Interest Income | 5↓42.4% | 9↑65.0% | 5↑566.2% | 0.78↑19.6% | 0.65 | |
| Interest Expense | 107↓15.3% | 126↓7.6% | 137↑130.6% | 59↓19.8% | 74 | |
| Non-Operating Income | 0.00↓100.0% | 8↑107.9% | -101↓221.8% | -31↓188.8% | 35 | |
| Other Income / Expenses | -607↓352.5% | -134↓273.1% | -36↓28.5% | -28↑74.4% | -109 | |
| Income Before Tax | -100↓206.9% | 93↓84.0% | 581↓6.7% | 623↑29.6% | 481 | |
| Income Tax Expense | 43↓37.1% | 68↓32.8% | 101↓22.6% | 130↑59.2% | 82 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -142↓662.1% | 25↓94.7% | 480↓2.5% | 493↑23.5% | 399 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -144↓1501.7% | 10↓97.8% | 475↓2.4% | 486↑24.4% | 391 | |
| Bottom-Line Net Income | -144↓1501.7% | 10↓97.8% | 475↓2.4% | 486↑24.4% | 391 | |
| EPS (Basic) | -2.91↓1555.0% | 0.20↓97.8% | 9.27↓3.1% | 9.57↑23.2% | 7.77 | |
| EPS (Diluted) | -2.91↓1555.0% | 0.20↓97.8% | 9.22↓2.7% | 9.48↑24.7% | 7.60 | |
| Weighted Average Shares | 50↓3.5% | 51↑0.3% | 51↑0.8% | 51↑1.0% | 50 | |
| Weighted Average Diluted Shares | 50↓4.0% | 52↑0.3% | 51↑0.3% | 51↓0.2% | 51 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.